Brain inflammation is often viewed as harmful in neurological diseases such as multiple sclerosis (MS), but a new animal study suggests that certain short-lived forms of inflammation may be needed to help the brain repair myelin. This finding may have important implications for understanding the biology of MS…

I don’t remember much about the support group meeting that changed everything. I don’t remember the facilitator’s name, the other people’s faces, how long we sat there, or what anyone actually said. What I remember is the moment, somewhere in the middle of someone else’s story, when I looked around…

Regulators in the European Union are recommendeding that tolebrutinib be approved as a treatment for people with secondary progressive multiple sclerosis (SPMS) who have not experienced a relapse in the last two years. That new positive opinion was issued by the European Medicines Agency’s Committee for Medicinal Products…

Ocrevus (ocrelizumab) delayed disability progression and worsening hand function among a large group of people with primary progressive multiple sclerosis (PPMS), including those who were older and had more advanced disease. The data, which come from the Phase 3 ORATORIO-HAND trial (NCT04035005), were presented by Jiwon Oh,…